Literature DB >> 24982414

Second primary malignancies in adult acute myeloid leukemia--A US population-based study.

Krishna Bilas Ghimire1, Binay Kumar Shah2.   

Abstract

BACKGROUND: Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. Long-term survivors from AML may be at higher risk of second primary malignancies. PATIENTS AND METHODS: We selected adult patients with AML aged≥18 years from the National Cancer Institute's Surveillance, Epidemiology and End RESULTS (SEER 13) database. We used the multiple primary standardized incidence ratio session of SEER*stat software to calculate the risk of second primary malignancies in patients with AML.
RESULTS: Among 5,091 patients, 148 patients developed a total of 160 second primary malignancies, with an observed/expected (O/E) ratio of 1.17, (95% confidence interval=0.99-1.36), and an excess risk of 15.47 per 10,000 population. The risk of all-site cancer, cancer of gastrointestinal system, and oral and pharyngeal cancer in different age groups was found to be significantly higher among patients with AML compared to that of general US population.
CONCLUSION: Adult patients with AML have a significantly higher risk of second primary malignancies compared to the general population. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  AML; SEER; leukemia; second primary malignancies

Mesh:

Year:  2014        PMID: 24982414

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Matrine regulates immune functions to inhibit the proliferation of leukemic cells.

Authors:  Lei Zhang; Huizhang Zhang; Zhichao Zhu; Lijia Jiang; Xuzhang Lu; Min Zhou; Xiao Sun; Liuyang He; Yu Bai; Lingdi Ma
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Atypical breast adenosquamous carcinoma following acute myeloid leukemia in a middle-aged woman: A case report.

Authors:  Seyed Mehdi Hashemi; Shokoufeh Mahmoudi Shan; Mahdi Jahantigh; Abolghasem Allahyari
Journal:  Mol Clin Oncol       Date:  2017-01-03

3.  Genome-Wide Gene Expression Profiling Defines the Mechanism of Anticancer Effect of Colorectal Cancer Cell-Derived Conditioned Medium on Acute Myeloid Leukemia.

Authors:  Ji-Eun Lee; Chan-Seong Kwon; Byeol-Eun Jeon; Woo Ryung Kim; Du Hyeong Lee; Sara Koh; Heui-Soo Kim; Sang-Woo Kim
Journal:  Genes (Basel)       Date:  2022-05-15       Impact factor: 4.141

4.  Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.

Authors:  Sara J Schonfeld; Lindsay M Morton; Amy Berrington de González; Rochelle E Curtis; Cari M Kitahara
Journal:  Cancer Epidemiol       Date:  2019-12-26       Impact factor: 2.984

5.  Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.

Authors:  Wenming Wang
Journal:  Biosci Rep       Date:  2019-06-14       Impact factor: 3.840

6.  A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia.

Authors:  Sufana Shikdar; Yuan Ying; Mohamad Khawandanah
Journal:  Leuk Res Rep       Date:  2022-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.